Music Therapy in Newly Diagnosed Glioblastoma After Chemoradiation Therapy (MELODY-GBM)

Recruiting N/A Interventional Study
Glioblastoma (GBM)
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
35 (estimated)
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The Brain Cancer Program, in partnership with the Center for Music and Medicine at Johns Hopkins, will study whether music therapy is feasible in newly diagnosed GBM patients undergoing standard care.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Glioblastoma (Newly Diagnosed) * Cognitive capacity to respond to surveys * Access to computer and web access * Ability to attend virtual music therapy sessions * Audibly process music * Proficient in English Exclusion Criteria: * Not planning to undergo standard of care rad…
Contacts

Principal Investigator- Matthias Holdhoff, MD, PhD.

410-995-8837

bcp-iis@jh.edu

CONTACT